Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis-Reference-Cited by-同舟云学术

Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis

Published:2017-09-28 Issue:13 Volume:130 Page:1578-1584
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Hwa Yi L.¹,Warsame Rahma¹^ORCID,Gertz Morie A.¹^ORCID,Buadi Francis K.¹^ORCID,Lacy Martha Q.¹,Kumar Shaji K.¹,Dingli David¹,Zeldenrust Steve R.¹,Leung Nelson¹²,Hayman Susanne R.¹,Kapoor Prashant¹,Gonsalves Wilson I.¹,Kourelis Taxiarchis V.¹,Russell Stephen¹,Go Ronald S.¹,Hobbs Miriam A.¹,Fonder Amie L.¹,Rajkumar S. Vincent¹³,Dispenzieri Angela¹³^ORCID

Affiliation:

1. Division of Hematology,

2. Division of Nephrology, and

3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Abstract

Key Points Organ progression at second-line therapy predicated inferior survival. Patients relapsing from >VGPR had a longer time to develop organ progression.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/130/13/1578/1402670/blood783415.pdf

Reference20 articles.

1. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment;Gertz;Am J Hematol,2014

2. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients;Comenzo;Blood,1996

3. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients;Comenzo;Blood,1998

4. Transplantation for amyloidosis;Gertz;Curr Opin Oncol,2007

5. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis;Sanchorawala;Amyloid,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation;Bone Marrow Transplantation;2023-12-26

2. Individualized Approach to Management of Light Chain Amyloidosis;Journal of the National Comprehensive Cancer Network;2023-01

3. Case Report: Renal relapse after heart transplantation, induction, and autologous stem cell transplantation in a patient with AL amyloidosis with exclusive cardiac involvement;Frontiers in Hematology;2022-10-11

4. Advances in the treatment of light chain amyloidosis;Current Opinion in Oncology;2022-08-04

5. Monitoring Patients with Light Chain (AL) Amyloidosis during and after Therapy: Response Assessment and Identification of Relapse;Hemato;2022-01-21